Speaker illustration

Miss Ana Belen Salido Medina

Instituto de Investigacion Sanitaria Valdecilla (IDIVAL), Santander (Spain)

Member of:

Heart Failure Association

Activation of bone morphogenetic protein type 1A receptors (BMPR1A) by THR184 halts the progression of the left ventricular remodelling under pressure overload

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Drugs, Drug Targets

Session: Moderated poster 4 AWARD


ESC 365 is supported by

logo Novo Nordisk